Marker Therapeutics Inc (MRKR)
3.50
-0.14
(-3.85%)
USD |
NASDAQ |
Nov 14, 16:00
3.50
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2020 | -1.36K% |
| March 31, 2020 | |
| December 31, 2019 | -2.38K% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -2.34K% |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -2.18K% |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 |
| Date | Value |
|---|---|
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.38K%
Minimum
Dec 2019
-1.36K%
Maximum
Jun 2020
-1.87K%
Average
-1.87K%
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -3.67K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -16.35% |
| Electromed Inc | 12.32% |
| Armata Pharmaceuticals Inc | -- |